What is the best way to take semaglutide?

Does the way you inject Wegovy actually change how well it works?

Yes, and the margins matter more than most people expect. The Wegovy pen is a subcutaneous injection, meaning the medicine goes into the fatty tissue just beneath the skin rather than into a vein or muscle. The three approved sites are the abdomen (avoiding the area immediately around the navel), the front of the thigh, and the outer upper arm. Each weekly dose should land in a different spot within that rotation; injecting into the same patch repeatedly can cause small areas of hardened or thickened tissue that slow absorption.

Pen technique is straightforward once you have done it a few times. Remove the pen from the fridge about 30 minutes beforehand, a cold injection is more uncomfortable than it needs to be, and letting the pen sit on the kitchen counter while you make breakfast is an easy habit to build. Clean the chosen site with an alcohol swab, pinch the skin gently, press the pen firmly against it and hold it in place for the full count after pressing the button. The NHS medicines guidance on semaglutide confirms that the pen should remain pressed to the skin until the injection is complete, to ensure the full dose is delivered.

Storage matters too. The pen lives in the fridge between 2°C and 8°C; once in use it may be kept at room temperature for a limited period, but the exact window is stated in the Patient Information Leaflet rather than here, because the rules differ between presentations. If you are unsure, the Wegovy information page gives a fuller orientation, and your prescriber can clarify storage for your specific pen format.

How should the Wegovy tablet be taken, and why does timing matter so much?

The oral form of semaglutide for weight loss (approved in the UK in June 2026 as the first oral GLP-1 medicine licensed for weight management) works through a very different mechanism to the injection, and that changes the daily routine significantly. The tablet must be taken first thing in the morning, on a completely empty stomach, with no more than a small sip of plain water (up to around 120 ml). After swallowing, you wait at least 30 minutes before eating anything, drinking anything other than plain water, or taking any other oral medicines.

This 30-minute window is not just a guideline. An absorption enhancer called SNAC helps semaglutide cross the stomach lining, but food, coffee or other medicines in the stomach at the same time disrupt that process substantially. In the OASIS 4 phase-3 trial, participants who stayed fully adherent to these instructions achieved around 17% average weight loss over 64 weeks, compared with approximately 13.6% across all participants regardless of adherence, a difference that traces directly back to whether the tablet was taken correctly. The trial data are summarised in the NHS medicines page for semaglutide.

For timing, first thing before the kettle boils is a reliable cue, the tablet, a small glass of water, then 30 minutes before anything else. Tablets should be swallowed whole and stored at room temperature, which makes the daily tablet considerably simpler for travel than the injection. If you want to explore which form might suit your routine, this page on taking semaglutide specifically for weight loss goes deeper on the comparison.

What about dose progression, can you move faster to a higher dose?

Titration is set by your prescriber, not by how you feel in week three. Both Wegovy injection and Wegovy tablets start at a low dose (0.25 mg weekly for the injection, 1.5 mg daily for the tablet) and step upward at roughly four-week intervals through a schedule that ends at 2.4 mg weekly (or, for those who reach it, the newly approved 7.2 mg dose with the dedicated single-dose pen) or 25 mg daily for the tablet. Each lower dose is there to settle gastrointestinal tolerance: nausea, vomiting and loose stools are most common when the dose changes, and moving too quickly almost always makes these worse rather than accelerating results.

Some people find a particular dose level causes persistent nausea. The right response is to tell your prescriber; they can pause the schedule, stay at the current dose for longer, or adjust based on your history, that is precisely the kind of oversight that makes a monitored private service different from obtaining medicine without a clinical assessment. The question of tolerance building over time is separate and worth reading about if you are months into treatment and wondering why progress has slowed.

NHS England's guidance on weight-management injections reinforces that titration decisions belong with the clinical team, not the patient's wish to move to a higher dose sooner. That said, if you reach a higher dose and genuinely need the prescription, how to access Wegovy in the UK explains the private and NHS routes side by side. On the pricing side, Wegovy pricing breaks down what to expect across the dose schedule.

What practical habits make the biggest difference week to week?

Consistency of day matters for the injection. Picking the same day each week (a Tuesday evening, for example) and attaching it to something fixed in your calendar makes it far harder to forget. If a dose is missed and more than five days have passed since it was due, the Patient Information Leaflet and your prescriber's advice take precedence over any general guidance here.

Alcohol does not interact with semaglutide directly, but it amplifies nausea during the first months and can blur the appetite signals the medicine works to recalibrate. Staying hydrated is especially important if gastrointestinal side effects are active, vomiting and diarrhoea together can cause dehydration quickly, and in that situation contacting your prescriber or seeking medical help is the right move rather than waiting it out. Timing your weekly injection relative to meals and social plans is another small adjustment that many people find helpful in the early weeks. And if you are ever considering stopping, stopping Wegovy safely is something to plan with your prescriber rather than do abruptly.

Finally, the lifestyle component is not decorative. Both the STEP 1 semaglutide trial data and clinical guidance (including from NHS England's weight-management injections guidance) make clear that reduced-calorie eating and increased activity are part of the licensed use. The medicine changes your appetite; what you do with that change shapes the outcome.

If you think semaglutide could be right for you and would like a clinical assessment, check your eligibility with our prescribers, the consultation is free, and a real clinician reviews your answers the same day.